Belinta 90 mg is an oral antiplatelet medication containing Ticagrelor, designed to reduce the risk of serious cardiovascular events such as heart attack, stroke, and death in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. It works by preventing platelets in the blood from sticking together and forming harmful clots, especially after stent placement or other heart procedures.